Literature DB >> 27722983

Relationships between Common and Novel Interleukin-6 Gene Polymorphisms and Risk of Cervical Cancer: a Case-Control Study.

Sabrina Zidi1, Mouna Stayoussef2, Bano L Alsaleh3, Ezzedine Gazouani4, Amel Mezlini5, Bashayer H Ebrahim3, Besma Yacoubi-Loueslati2, Wassim Y Almawi3.   

Abstract

We investigated the association between six common and novel interleukin-6 (IL-6) polymorphisms with the risk of cervical cancer (CC) among Tunisians. Study subjects comprised 112 CC cases and 164 control women. Genotyping of IL-6 rs2069845, rs2069840, rs1474348, rs1800795, rs1800797, rs2069827 variants was done by real-time PCR, with defined clusters. The allelic and genotypic distributions of the tested IL-6 SNPs were comparable between CC patients and control women. Stratification according to FIGO staging revealed that rs1800795 homozygous major allele genotype (P = 0.033; OR =0.49(0.25-0.95)) and major allele (P = 0.037; OR = 0.57 (0.33-0.97)) were protective of CC. Moreover, carriage of rs1474348 major allele was also protective of CC (P = 0.014; OR = 0.53(0.32-0.88)), while higher rs1474348 minor allele frequency was seen in CC patients with early FIGO stage (P = 0.044; OR = 0.39 (0.15-1.00)), thus implicating rs1474348 in CC evolution and progression of angiogenesis. Haploview analysis demonstrated high linkage disequilibrium (LD) between rs2069845, rs2069840, rs1474348 and rs1800795, and 6-locus haplotype analysis identified GACCCA haplotype to be positively associated with increased CC, while GAGGGG haplotype was negatively associated with CC, thus suggesting a protective role for this haplotype in CC. Furthermore, there was a significant association between the incidence of CC and the use hormonal contraception (P = 0.047; OR = 1.97 (0.94-4.13)) and smoking (P < 0.001; OR = 7.12 (2.97-17.04)). The IL-6 variants rs1800795 and rs1474348, and haplotypes GACCCA and GAGGGG, along with use of hormonal contraceptives and smoking, are major risk factors of CC susceptibility and evolution among Tunisian women.

Entities:  

Keywords:  Cervical cancer; FIGO stages; Haplotypes; Interleukin-6; Polymorphisms; Tunisians

Mesh:

Substances:

Year:  2016        PMID: 27722983     DOI: 10.1007/s12253-016-0127-9

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Location and Density of Immune Cells in Precursor Lesions and Cervical Cancer.

Authors:  Astrid M Bedoya; Roberto Jaramillo; Armando Baena; Jorge Castaño; Natalia Olaya; Arnold H Zea; Rolando Herrero; Gloria I Sanchez
Journal:  Cancer Microenviron       Date:  2012-01-31

2.  Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women.

Authors:  Mangalathu S Rajeevan; David C Swan; Rosane Nisenbaum; Daisy R Lee; Suzanne D Vernon; Mack T Ruffin; Ira R Horowitz; Lisa C Flowers; David Kmak; Talaat Tadros; George Birdsong; Mujtaba Husain; Sudhir Srivastava; Elizabeth R Unger
Journal:  Int J Cancer       Date:  2005-05-20       Impact factor: 7.396

3.  Relationship of common vascular endothelial growth factor polymorphisms and haplotypes with the risk of cervical cancer in Tunisians.

Authors:  Sabrina Zidi; Mouna Stayoussef; Ezzedine Gazouani; Amel Mezlini; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Cytokine       Date:  2014-12-23       Impact factor: 3.861

Review 4.  Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies.

Authors:  Paul Appleby; Valerie Beral; Amy Berrington de González; Didier Colin; Silvia Franceschi; Adrian Goodhill; Jane Green; Julian Peto; Martyn Plummer; Siân Sweetland
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

5.  Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model.

Authors:  B E Barton; J V Jackson
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

6.  Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells.

Authors:  Siddig Ibrahim Abdelwahab; Ahmad Bustamam Abdul; Zetty Nadia Mohd Zain; A Hamid A Hadi
Journal:  Int Immunopharmacol       Date:  2012-02-11       Impact factor: 4.932

7.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

8.  Polymorphisms of the Interleukin 6 gene contribute to cervical cancer susceptibility in Eastern Chinese women.

Authors:  Ting-Yan Shi; Mei-Ling Zhu; Jing He; Meng-Yun Wang; Qiao-Xin Li; Xiao-Yan Zhou; Meng-Hong Sun; Zhi-Ming Shao; Ke-Da Yu; Xi Cheng; Xiaohua Wu; Qingyi Wei
Journal:  Hum Genet       Date:  2012-11-20       Impact factor: 4.132

9.  Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer.

Authors:  E Vairaktaris; A Yiannopoulos; A Vylliotis; C Yapijakis; S Derka; S Vassiliou; E Nkenke; Z Serefoglou; V Ragos; C Tsigris; E Vorris; E Critselis; D Avgoustidis; F W Neukam; E Patsouris
Journal:  Int J Biol Markers       Date:  2006 Oct-Dec       Impact factor: 3.248

10.  Association of Combined Tobacco Smoking and Oral Contraceptive Use With Cervical Intraepithelial Neoplasia 2 or 3 in Korean Women.

Authors:  Hea Young Oh; Mi Kyung Kim; Sang-Soo Seo; Jae-Kwan Lee
Journal:  J Epidemiol       Date:  2015-10-03       Impact factor: 3.211

View more
  12 in total

1.  Effect of Follicle Stimulating Hormone Receptor Gene Polymorphisms in Cervical Cancer Risk.

Authors:  Sabrina Zidi; Mouna Stayoussef; Bano L Alsaleh; Ezzedine Gazouani; Amel Mezlini; Bashayer H Ebrahim; Besma Yacoubi-Loueslati; Wassim Y Almawi
Journal:  Pathol Oncol Res       Date:  2016-11-14       Impact factor: 3.201

2.  Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis.

Authors:  Xingchun Peng; Jun Shi; Wanqun Sun; Xuzhi Ruan; Yang Guo; Lunhua Zhao; Jue Wang; Bin Li
Journal:  Oncotarget       Date:  2018-01-05

3.  Association of IL-6 -174G>C (rs1800795) polymorphism with cervical cancer susceptibility.

Authors:  Hai-Xia Duan; You-Yi Chen; Juan-Zi Shi; Nan-Nan Ren; Xiao-Juan Li
Journal:  Biosci Rep       Date:  2018-09-13       Impact factor: 3.840

4.  The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case-control study.

Authors:  Fanglin Niu; Tianchang Wang; Jing Li; Mengdan Yan; Dianzhen Li; Bin Li; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2018-11-20       Impact factor: 2.183

5.  Association between IL1B gene and cervical cancer susceptibility in Chinese Uygur Population: A Case-Control study.

Authors:  Li Wang; Wenhui Zhao; Jiajing Hong; Fanglin Niu; Jing Li; Shanshan Zhang; Tianbo Jin
Journal:  Mol Genet Genomic Med       Date:  2019-06-20       Impact factor: 2.183

6.  Association of IL-12B rs3212227 and IL-6 rs1800795 Polymorphisms with Susceptibility to Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mojgan Karimi-Zarchi; Hajar Abbasi; Atiyeh Javaheri; Amaneh Hadadan; Bahare Meibodi; Razieh Sadat Tabatabaei; Yaser Ghelmani; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01

7.  Single nucleotide polymorphism of transforming growth factor-β1 and interleukin-6 as risk factors for ovarian cancer.

Authors:  Amira Ben Ahmed; Sabrina Zidi; Wassim Almawi; Ezzeddine Ghazouani; Amel Mezlini; Besma Yacoubi Loueslati; Mouna Stayoussef
Journal:  Cent Eur J Immunol       Date:  2020-11-01       Impact factor: 2.085

8.  Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk.

Authors:  Md Harun-Or-Roshid; Md Borqat Ali; Md Nurul Haque Mollah
Journal:  PLoS One       Date:  2021-03-08       Impact factor: 3.752

Review 9.  A Review of Cancer Genetics and Genomics Studies in Africa.

Authors:  Solomon O Rotimi; Oluwakemi A Rotimi; Bodour Salhia
Journal:  Front Oncol       Date:  2021-02-15       Impact factor: 5.738

10.  IL-6 597A/G (rs1800797) and 174G/C (rs1800795) Gene Polymorphisms in the Development of Cervical Cancer in Lithuanian Women.

Authors:  Agne Vitkauskaite; Joana Celiesiute; Vijoleta Juseviciute; Kristina Jariene; Erika Skrodeniene; Gabriele Samuolyte; Ruta Jolanta Nadisauskiene; Daiva Vaitkiene
Journal:  Medicina (Kaunas)       Date:  2021-09-26       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.